These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 9158517

  • 1. When is bone scintigraphy necessary in the assessment of newly diagnosed, untreated prostate cancer?
    Haukaas S, Roervik J, Halvorsen OJ, Foelling M.
    Br J Urol; 1997 May; 79(5):770-6. PubMed ID: 9158517
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Serum prostate-specific antigen as a predictor of radiographic staging studies in newly diagnosed prostate cancer.
    Huncharek M, Muscat J.
    Cancer Invest; 1995 May; 13(1):31-5. PubMed ID: 7530590
    [Abstract] [Full Text] [Related]

  • 4. Influence of local tumour stage and grade on reliability of serum prostate-specific antigen in predicting skeletal metastases in patients with adenocarcinoma of the prostate.
    Bruwer G, Heyns CF, Allen FJ.
    Eur Urol; 1999 May; 35(3):223-7. PubMed ID: 10072624
    [Abstract] [Full Text] [Related]

  • 5. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
    Wang TY, Chen XP, Li XS, Jia Yx, Cheng J, Zhang JH, Cai L, Zhang Z, Gong K, He ZS, Zhou LQ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug 18; 44(4):528-34. PubMed ID: 22898839
    [Abstract] [Full Text] [Related]

  • 6. Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer.
    Moslehi M, Cheki M, Salehi-Marzijarani M, Amuchastegui T, Gholamrezanezhad A.
    Rev Esp Med Nucl Imagen Mol; 2013 Aug 18; 32(5):286-9. PubMed ID: 23478119
    [Abstract] [Full Text] [Related]

  • 7. Can initial prostate specific antigen determinations eliminate the need for bone scans in patients with newly diagnosed prostate carcinoma? A multicenter retrospective study in Japan.
    Kosuda S, Yoshimura I, Aizawa T, Koizumi K, Akakura K, Kuyama J, Ichihara K, Yonese J, Koizumi M, Nakashima J, Fujii H.
    Cancer; 2002 Feb 15; 94(4):964-72. PubMed ID: 11920464
    [Abstract] [Full Text] [Related]

  • 8. Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients.
    Lorente JA, Valenzuela H, Morote J, Gelabert A.
    Eur J Nucl Med; 1999 Jun 15; 26(6):625-32. PubMed ID: 10369948
    [Abstract] [Full Text] [Related]

  • 9. Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: feasibility in Asian population.
    Lai MH, Luk WH, Chan JC.
    Urol Oncol; 2011 Jun 15; 29(3):275-9. PubMed ID: 19734069
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Serum prostate-specific antigen as a predictor of staging abdominal/pelvic computed tomography in newly diagnosed prostate cancer.
    Huncharek M, Muscat J.
    Abdom Imaging; 1996 Jun 15; 21(4):364-7. PubMed ID: 8661585
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Ability of serum prostate-specific antigen levels to predict normal bone scans in patients with newly diagnosed prostate cancer.
    Gleave ME, Coupland D, Drachenberg D, Cohen L, Kwong S, Goldenberg SL, Sullivan LD.
    Urology; 1996 May 15; 47(5):708-12. PubMed ID: 8650870
    [Abstract] [Full Text] [Related]

  • 14. Is prostate-specific antigen a reliable marker of bone metastasis in patients with newly diagnosed cancer of the prostate?
    Wolff JM, Zimny M, Borchers H, Wildberger J, Buell U, Jakse G.
    Eur Urol; 1998 May 15; 33(4):376-81. PubMed ID: 9612680
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer.
    Oesterling JE, Martin SK, Bergstralh EJ, Lowe FC.
    JAMA; 1993 Jan 06; 269(1):57-60. PubMed ID: 7677962
    [Abstract] [Full Text] [Related]

  • 20. [Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer].
    Kageyama Y, Kihara K, Kamata S, Nagahama K, Yonese J, Fukuda H, Tosaka A, Nagamatsu H, Ishizaka K, Tsujii T, Kitahara S, Morita T, Oshima H.
    Hinyokika Kiyo; 1996 Mar 06; 42(3):197-9. PubMed ID: 8619388
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.